Cortina Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Cortina Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,452	Closed	-$458K	–	291
2014 Q4	$458K	Buy	14,452 +684	+5%	+$20K	0.02%	257
2014 Q3	$326K	Sell	13,768 -8,600	-38%	-$220K	0.01%	256
2014 Q2	$671K	Sell	22,368 -4,662	-17%	-$126K	0.03%	231
2014 Q1	$714K	Buy	+27,030	New	+$676K	0.03%	223

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Cortina Asset Management's IPXL Position: Q1 2015 in Review

Cortina Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2015, closing a stake of 14,452 shares — an estimated $458K sold.

Cortina Asset Management first reported a position in IPXL in Q1 2014 and held it in 4 quarters. The position peaked at $714K in Q1 2014. 197 funds tracked by Wall St. Rank hold IPXL as of Q1 2015.

Cortina Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2015 after selling out during the quarter.
Cortina Asset Management sold 14,452 Impax Laboratories, Inc. shares in Q1 2015, an estimated $458K.
Cortina Asset Management first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 4 quarters.
Cortina Asset Management's Impax Laboratories, Inc. position peaked at $714K in Q1 2014.
197 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2015.

Based on Cortina Asset Management's 13F filing for Q1 2015, filed 16 Apr 2015.